{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:52:49Z","timestamp":1762001569755,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T00:00:00Z","timestamp":1514419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ymgmr.2017.12.005","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:19:29Z","timestamp":1515716369000},"page":"11-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement"],"prefix":"10.1016","volume":"15","author":[{"given":"Ahmed N.","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn A.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paldeep S.","family":"Atwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.ymgmr.2017.12.005_bb0005","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1101\/gad.10.24.3156","article-title":"Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis","volume":"10","author":"Bonten","year":"1996","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.ymgmr.2017.12.005_bb0010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/glycob\/cws057","article-title":"Mammalian sialidases: physiological and pathological roles in cellular functions","volume":"22","author":"Miyagi","year":"2012","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.ymgmr.2017.12.005_bb0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/humu.10278","article-title":"Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression","volume":"23","author":"Pattison","year":"2004","journal-title":"Hum. Mutat."},{"issue":"7","key":"10.1016\/j.ymgmr.2017.12.005_bb0020","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/9.7.1075","article-title":"Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex","volume":"9","author":"Lukong","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"S2","key":"10.1016\/j.ymgmr.2017.12.005_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1684\/epd.2016.0845","article-title":"Sialidoses","volume":"18","author":"Franceschetti","year":"2016","journal-title":"Epileptic Disord."},{"issue":"5","key":"10.1016\/j.ymgmr.2017.12.005_bb0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/humu.10268","article-title":"Molecular pathology of NEU1 gene in sialidosis","volume":"22","author":"Seyrantepe","year":"2003","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.ymgmr.2017.12.005_bb0035","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0022-3476(80)80734-7","article-title":"A severe infantile sialidosis: clinical, biochemical, and microscopic features","volume":"96","author":"Aylsworth","year":"1980","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgmr.2017.12.005_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00445802","article-title":"Neuraminidase deficiency presenting as non-immune hydrops fetalis","volume":"143","author":"Beck","year":"1984","journal-title":"Eur. J. Pediatr."},{"issue":"18","key":"10.1016\/j.ymgmr.2017.12.005_bb0045","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/hmg\/9.18.2715","article-title":"Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis","volume":"9","author":"Bonten","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"22","key":"10.1016\/j.ymgmr.2017.12.005_bb0050","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.0000000000000482","article-title":"Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonus","volume":"82","author":"Canafoglia","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgmr.2017.12.005_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ng.3144","article-title":"A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy","volume":"47","author":"Muona","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgmr.2017.12.005_bb0060","first-page":"9","article-title":"Pitfalls in diagnosing neuraminidase deficiency: psychosomatics and normal sialic acid excretion","volume":"25","author":"Schene","year":"2016","journal-title":"JIMD Rep."},{"issue":"4","key":"10.1016\/j.ymgmr.2017.12.005_bb0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ana.410170409","article-title":"The cherry-red spot in Tay-Sachs and other storage diseases","volume":"17","author":"Kivlin","year":"1985","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ymgmr.2017.12.005_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1399-0004.2011.01625.x","article-title":"Lysosomal multienzymatic complex-related diseases: a genetic study among Portuguese patients","volume":"81","author":"Coutinho","year":"2012","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.ymgmr.2017.12.005_bb0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jchromb.2006.10.066","article-title":"Quantification of free and total sialic acid excretion by LC-MS\/MS","volume":"848","author":"van der Ham","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ymgmr.2017.12.005_bb0080","first-page":"43","article-title":"Mutations in the complex III assembly factor tetratricopeptide 19 gene TTC19 are a rare cause of leigh syndrome","volume":"14","author":"Atwal","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2017.12.005_bb0085","first-page":"94","article-title":"Case report: 5 year follow-up of adult late-onset mitochondrial encephalomyopathy with lactic acid and stroke-like episodes (MELAS)","volume":"9","author":"Sunde","year":"2016","journal-title":"Mol. Gen. Metab. Rep."},{"issue":"10","key":"10.1016\/j.ymgmr.2017.12.005_bb0090","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/humu.23047","article-title":"Silent tyrosinemia type I without elevated tyrosine or succinylacetone associated with liver cirrhosis and hepatocellular carcinoma","volume":"37","author":"Blackburn","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2017.12.005_bb0095","first-page":"40","article-title":"Holocarboxylase synthetase deficiency pre and post newborn screening","volume":"7","author":"Donti","year":"2016","journal-title":"Mol. Gen. Metab. Rep."},{"issue":"4","key":"10.1016\/j.ymgmr.2017.12.005_bb0100","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ajmg.a.37491","article-title":"Novel X-linked syndrome of cardiac valvulopathy, keloid scarring, and reduced joint mobility due to filamin A substitution G1576R","volume":"170A","author":"Atwal","year":"2016","journal-title":"Am. J. Med. Gen. Part A"},{"key":"10.1016\/j.ymgmr.2017.12.005_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/TACG.S125962","article-title":"Maple syrup urine disease: mechanisms and management","volume":"10","author":"Blackburn","year":"2017","journal-title":"Appl. Clin. Genet."},{"issue":"3","key":"10.1016\/j.ymgmr.2017.12.005_bb0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mgg3.280","article-title":"Whole exome sequencing of a patient with suspected mitochondrial myopathy reveals novel compound heterozygous variants in RYR1","volume":"5","author":"Blackburn","year":"2017","journal-title":"Mol. Gen. Genomic Med."},{"issue":"3","key":"10.1016\/j.ymgmr.2017.12.005_bb0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/CND.0000000000000164","article-title":"Whole exome sequencing identifies atypical welander distal myopathy in patient","volume":"18","author":"Gass","year":"2017","journal-title":"J. Clin. Neuromuscul. Dis."},{"issue":"9","key":"10.1016\/j.ymgmr.2017.12.005_bb0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/gim.2014.10","article-title":"Clinical whole-exome sequencing: are we there yet?","volume":"16","author":"Atwal","year":"2014","journal-title":"Genitourin. Med."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426917301489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426917301489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:50:33Z","timestamp":1762001433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426917301489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":24,"alternative-id":["S2214426917301489"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2017.12.005","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2017.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}